Switch to: References

Add citations

You must login to add citations.
  1. Formulating an Ethics of Pharmaceutical Disinvestment.Jessica Pace, Tracey-Lea Laba, Marie-Paul Nisingizwe & Wendy Lipworth - 2020 - Journal of Bioethical Inquiry 17 (1):75-86.
    There is growing interest among pharmaceutical policymakers in how to “disinvest” from subsidized medicines. This is due to both the rapidly rising costs of healthcare and the increasing use of accelerated and conditional reimbursement pathways which mean that medicines are being subsidized on the basis of less robust evidence of safety and efficacy. It is crucial that disinvestment decisions are morally sound and socially legitimate, but there is currently no framework to facilitate this. We therefore reviewed the bioethics literature in (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Investigation of post-trial access views among study participants and stakeholders using photovoice and semistructured interviews.Nothando Ngwenya, Collins Iwuji, Nabeel Petersen, Nompilo Myeni, Samukelisiwe Nxumalo, Ursula Ngema & Janet Seeley - 2022 - Journal of Medical Ethics 48 (10):712-717.
    Purpose We examine the levels of post-trial responsibility ascribed to different stakeholders, following a community-based clinical trial and how the ‘responsibility’ is understood. Methods We employed photovoice, unstructured observations and key informant interviews to gain insights into contexts of access to care following transition to the public health system post trial. We used an inductive narrative analysis to explore experiences and understandings of post-trial access. Results In their photovoice stories, many participants expressed a sense of abandonment after the trial. This (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation